PRINCETON, N.J., Dec. 2 Novo Nordisk said today that the U.S. Food and Drug Administration (FDA) has approved a 10 mcg dose formulation of Vagifem® (estradiol vaginal tablets) for the treatment of ...

The FDA has approved a 10 mg formulation of Vagifem (estradiol vaginal tablets, from Novo Nordisk) for the treatment of atrophic vaginitis due to menopause. This approval is based on clinical data ...

PRINCETON, N.J., May 20 Novo Nordisk Inc. announced today that Vagifem® (estradiol vaginal tablets) 10 mcg will become the only available formulation of Vagifem® in the U.S., in line with medical ...

Novo Nordisk announced that Vagifem (estradiol hemihydrate vaginal tablets) 10mcg will become the only available formulation of Vagifem for the treatment of atrophic vaginitis. This action is in ...

Novo Nordisk introduced Vagifem® 10 mcg to the U.S. market earlier this year. The new dose replaces Vagifem® 25 mcg dose, which was discontinued on July 30, 2010. "This partnership with Upsher-Smith ...

HYDERABAD: Aurobindo Pharma Limited on Tuesday informed the bourses that it has received final approval from the US Food & Drug Administration (USFDA) for manufacturing and marketing Estradiol vaginal ...